Mi-Hyung Kim
Chief Executive Officer bei ANTEROGEN.CO.,LTD.
Vermögen: 902 287 $ am 30.04.2024
Profil
Mi-Hyung Kim currently works at Anterogen Co., Ltd., as Co-Chief Executive Officer and Morgan Stanley & Co. International Plc (South Korea), as Analyst.
Dr. Kim received her graduate degree from Seoul National University and undergraduate degree and doctorate degree from Ewha Womans University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ANTEROGEN CO., LTD.
0,89% | 30.09.2023 | 86 661 ( 0,89% ) | 902 287 $ | 30.04.2024 |
Aktive Positionen von Mi-Hyung Kim
| Unternehmen | Position | Beginn |
|---|---|---|
| ANTEROGEN.CO.,LTD. | Chief Executive Officer | - |
Morgan Stanley & Co. International Plc (South Korea)
 Morgan Stanley & Co. International Plc (South Korea) Investment Banks/BrokersFinance Morgan Stanley & Co. International Plc (South Korea) is the South Korean brokerage division of Great Britain-based Morgan Stanley & Co. International Plc, ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in Seoul, the firm was founded in 1996 and provides prime brokerage and execution services and solutions to institutional clients. | Analyst-Equity | - |
Ausbildung von Mi-Hyung Kim
| Seoul National University | Graduate Degree |
| Ewha Womans University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Morgan Stanley & Co. International Plc (South Korea)
Morgan Stanley & Co. International Plc (South Korea) Investment Banks/BrokersFinance Morgan Stanley & Co. International Plc (South Korea) is the South Korean brokerage division of Great Britain-based Morgan Stanley & Co. International Plc, ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in Seoul, the firm was founded in 1996 and provides prime brokerage and execution services and solutions to institutional clients. | Finance |
| Anterogen Co., Ltd. |
